Literature DB >> 11304531

Parallel regulation of mitogen-activated protein kinase kinase 3 (MKK3) and MKK6 in Gq-signaling cascade.

J Yamauchi1, G Tsujimoto, Y Kaziro, H Itoh.   

Abstract

Heterotrimeric G protein G(q) stimulates the activity of p38 mitogen-activated protein kinase (MAPK) in mammalian cells. To investigate the signaling mechanism whereby alpha and betagamma subunits of G(q) activate p38 MAPK, we introduced kinase-deficient mutants of mitogen-activated protein kinase kinase 3 (MKK3), MKK4, and MKK6 into human embryonal kidney 293 cells. The activation of p38 MAPK by Galpha(q) and Gbetagamma was blocked by kinase-deficient MKK3 and MKK6 but not by kinase-deficient MKK4. In addition, Galpha(q) and Gbetagamma stimulated MKK3 and MKK6 activities. The MKK3 and MKK6 activations by Galpha(q), but not by Gbetagamma, were dependent on phospholipase C and c-Src. Galpha(q) stimulated MKK3 in a Rac- and Cdc42-dependent manner and MKK6 in a Rho-dependent manner. On the other hand, Gbetagamma activated MKK3 in a Rac- and Cdc42-dependent manner and MKK6 in a Rho-, Rac-, and Cdc42-dependent manner. Gbetagamma-induced MKK3 and MKK6 activations were dependent on a tyrosine kinase other than c-Src. These results suggest that Galpha(q) and Gbetagamma stimulate the activity of p38 MAPK by regulating MKK3 and MKK6 through parallel signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11304531     DOI: 10.1074/jbc.M011752200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  G protein-coupled receptors activate p38 MAPK via a non-canonical TAB1-TAB2- and TAB1-TAB3-dependent pathway in endothelial cells.

Authors:  Neil J Grimsey; Ying Lin; Rachan Narala; Cara C Rada; Hilda Mejia-Pena; JoAnn Trejo
Journal:  J Biol Chem       Date:  2019-02-13       Impact factor: 5.157

2.  Expression of Galpha 13 (Q226L) induces P19 stem cells to primitive endoderm via MEKK1, 2, or 4.

Authors:  Hsien-yu Wang; Jyotshnabala Kanungo; Craig C Malbon
Journal:  J Biol Chem       Date:  2001-11-07       Impact factor: 5.157

3.  The Candida albicans toxin candidalysin mediates distinct epithelial inflammatory responses through p38 and EGFR-ERK pathways.

Authors:  Spyridoula-Angeliki Nikou; Chunsheng Zhou; James S Griffiths; Natalia K Kotowicz; Bianca M Coleman; Mary J Green; David L Moyes; Sarah L Gaffen; Julian R Naglik; Peter J Parker
Journal:  Sci Signal       Date:  2022-04-05       Impact factor: 8.192

Review 4.  Unlocking the Untapped Potential of Endothelial Kinase and Phosphatase Involvement in Sepsis for Drug Treatment Design.

Authors:  Matthijs Luxen; Matijs van Meurs; Grietje Molema
Journal:  Front Immunol       Date:  2022-05-13       Impact factor: 8.786

5.  Mechanisms of kringle fragment of urokinase-induced vascular smooth muscle cell migration.

Authors:  Elisa Roztocil; Suzanne M Nicholl; Mark G Davies
Journal:  J Surg Res       Date:  2007-07       Impact factor: 2.192

6.  Role of Src signal transduction pathways in scatter factor-mediated cellular protection.

Authors:  Saijun Fan; Qinghui Meng; John J Laterra; Eliot M Rosen
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

7.  Neurotrophin 3 activation of TrkC induces Schwann cell migration through the c-Jun N-terminal kinase pathway.

Authors:  Junji Yamauchi; Jonah R Chan; Eric M Shooter
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205

8.  Multiple Gi proteins participate in nerve growth factor-induced activation of c-Jun N-terminal kinases in PC12 cells.

Authors:  Prudence H Tso; Christina J Morris; Lisa Y Yung; Nancy Y Ip; Yung H Wong
Journal:  Neurochem Res       Date:  2008-11-14       Impact factor: 3.996

9.  2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin promotes endothelial cell apoptosis through activation of EP3/p38MAPK/Bcl-2 pathway.

Authors:  Yu Yu; Qian Liu; Shumin Guo; Qianqian Zhang; Juan Tang; Guizhu Liu; Deping Kong; Juanjuan Li; Shuai Yan; Ruiguo Wang; Peilong Wang; Xiaoou Su; Ying Yu
Journal:  J Cell Mol Med       Date:  2017-07-12       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.